Eli Lilly (LLY) has signed a deal with AI startup profluent worth up to USD 2.25bln to find new ways to edit DNA

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

A Japanese oil tanker passes through the Strait of Hormuz with Iran's coordination; Idemitsu is an oil tanker that was carrying 2mln bbls of crude oil; it had been stationed in Saudi Arabia since late February

Coca-Cola (KO) CFO says bottlers would have greater impact if higher aluminum and pet prices sustain; on aluminum can shortage in India says, 'have had some disruption in can supply and our cross enterprise procurement team'

Eli Lilly (LLY) has signed a deal with AI startup profluent worth up to USD 2.25bln to find new ways to edit DNA

UK Chancellor Reeves says she will do all she can to help renters when asked about a possible freeze for private-sector rents

IATA's Walsh says current jet fuel crisis is not on the scale of covid, demand for flying continues to be strong

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

Eli Lilly's significant investment in AI startup Profluent highlights a strategic push into advanced biotechnology, particularly in DNA editing. This partnership could enhance LLY’s research capabilities and pipeline, potentially impacting its competitive edge in the pharmaceutical sector. Investors will be keen to assess the deal's long-term benefits against its cost, as well as broader implications for peers in biotechnology and life sciences.

Related headlines

The feed had this first.

Use the Platform